Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients

被引：0
|
作者：
Tokito, Takaaki [1 ]
Azuma, Koichi [1 ]
Ishii, Hidenobu [1 ]
Yamada, Kazuhiko [1 ]
Hoshino, Tomoaki [1 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3-1-3
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [31] Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer.
    Rizvi, Hira
    Bandlamudi, Chaitanya
    Schoenfeld, Adam Jacob
    Sauter, Jennifer L.
    Arbour, Kathryn Cecilia
    Beras, Amanda
    Egger, Jacklynn V.
    Ladanyi, Marc
    Donoghue, Mark
    Rudin, Charles M.
    Taylor, Barry S.
    Hellmann, Matthew David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] PD-L1 Expression in Patients with Non-Small Cell Lung Cancer According to Underlying Pulmonary Disease: A Retrospective Study
    Ohara, S.
    Saihara, A.
    Matsumoto, Y.
    Furukawa, R.
    Taniguchi, Y.
    Sato, A.
    Hojo, M.
    Usui, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1914 - S1914
  • [33] Expression analysis of programmed cell death 1 ligand 1 (PD-L1) in patients with non-small cell lung cancer
    Peng, Nanqiu
    Qin, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (01): : 1 - 5
  • [34] PD-L1 and molecular biomarker expression in non-small cell lung cancer in Tunisian patients
    Houcine, Yoldez
    Moussa, Chirine
    Ben Abdelaziz, Ahmed
    Ayadi, Aida
    MONALDI ARCHIVES FOR CHEST DISEASE, 2024, 94 (04)
  • [35] Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Dellepiane, C.
    Coco, S.
    Dal Bello, M. G.
    Rossi, G.
    Rijavec, E.
    Biello, F.
    Tagliamento, M.
    Longo, L.
    Mora, M.
    Anselmi, G.
    Alama, A.
    Bennicelli, E.
    Grossi, F.
    Zullo, L.
    Beshiri, K.
    Bottini, A.
    Pronzato, P.
    Genova, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S851 - S851
  • [36] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Efficacy of Chemo-Radiotherapy (CRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression
    Adam, Julien
    Boros, Angela
    Lacas, Benjamin
    Lacroix, Ludovic
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    Besse, Benjamin
    Le Pechoux, Cecile
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S244 - S244
  • [38] Evaluation of the prognostic marker of PD-L1 expression after combined radiochemotherapy in patients with non-small cell lung cancer (NSCLC) stage III
    Wagner, Jan
    Roeper, Julia
    Willborn, Kay
    Griesinger, Frank
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 159 - 159
  • [39] The prognostic value of PD-L1 expression for non-small cell lung cancer patients: A meta-analysis
    Wang, A.
    Wang, H. Y.
    Liu, Y.
    Zhao, M. C.
    Zhang, H. J.
    Lu, Z. Y.
    Fang, Y. C.
    Chen, X. F.
    Liu, G. T.
    EJSO, 2015, 41 (04): : 450 - 456
  • [40] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
    Kerr, Keith M.
    Nicolson, Marianne C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254
12345